stella
beta
Plasma a-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Neurodegeneration Disease — Stella
Home
/
RT-QuIC
/
Plasma a-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Neurodegeneration Disease
View on ClinicalTrials.gov
Recruiting
Back to RT-QuIC trials
Plasma a-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Neurodegeneration Disease
Trial locations
(2 sites)
China
Xuanwu Hospital, Beijing, Beijing Municipality
Xuanwu Hospital, Beijing, Beijing Municipality